Back to Overview
Martin Fabry PhD
Martin Fabry finished his bachelor’s degree in molecular biomedicine at the University of Bonn in 2014 and moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York, US) working on improving CRISPR/Cas9 technologies. Following completion of a master’s degree in life and medical sciences in 2016 with emphasis on molecular mechanisms of immunity, Martin started his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge studying genome organisation and stability.
After graduating with his doctorate degree in 2020, Martin worked as postdoctoral fellow in computational biology at the Gurdon Institute and European Bioinformatics Institute (EBI) in Cambridge with focus on stem cell development and establishing new technologies for stem cell differentiation.
Martin joined IP2 in 2018 as scientific consultant and started as a patent attorney candidate in late 2021.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
22 years: bäng-dänge-däng-däng
... this is how a short sequence from the piece "Metall auf Metall" (metal on metal), which can be found on the album "Trans Europa Express" by the German band Kraftwerk from 1977, can be described. And it is precisely this beat, lasting just 2 seconds, that is at...
What the expert knows…
In a recently published decision (1), the German Federal Court of Justice (BGH) once again addressed the issue of the role of the knowledge of a person skilled in the art in the assessment of inventive step. This provides an opportunity to examine this question...
G 2/21: The Desaster failed
After almost two years of waiting, the Enlarged Board of Appeal published their long-awaited - some would say feared - decision G 2/21 on March 23, 2023 (1). In a nut shell: the disaster fails. But in detail: What is it about? Briefly, about the question of the...
Back to Overview